Consonance Capital Management LP Apellis Pharmaceuticals, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$25.89 - $33.65 $258,900 - $336,500
-10,000 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$17.91 - $44.33 $2.24 Million - $5.54 Million
-125,000 Reduced 92.59%
10,000 $268,000
Q4 2019

Feb 14, 2020
BUY
$22.1 - $30.8 $2.98 Million - $4.16 Million
135,000 New
135,000 $4.13 Million

Others Institutions Holding APLS

# of Institutions
303
Shares Held
112M
Call Options Held
5.03M
Put Options Held
703K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.1B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email